Can a computer alert help doctors treat kidney disease better?

NCT ID NCT07430930

Not yet recruiting Knowledge-focused Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 12, 2026 · Updated 3 times

Summary

This study tests whether a pop-up alert in electronic medical records helps doctors prescribe more recommended medications for chronic kidney disease (CKD). About 1,000 patients with CKD will be included, and their doctors will either see the alert or not. The goal is to see if the alert increases prescriptions of drugs like ACE inhibitors and SGLT2 inhibitors within 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Best practice alert and order set (clinical decision support tool)
What this could lead to: If successful, this could show that simple electronic alerts help doctors prescribe more guideline-recommended medications for CKD, potentially improving patient outcomes.
What could go wrong: This is a pragmatic trial focused on provider behavior, not a direct test of a new drug. It may not show clear benefits for patients, and results may not apply to other healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASES

Contacts and locations

Locations

Yale New Haven Health

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.